BioSpace News Archive

Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced the appointment of former chief executive officer of Constellation Pharmaceuticals and former Jounce chief business officer, Jigar Raythatha, to its board of directors.

After months of developmental groundwork, MedCAD is proud to officially announce FDA 510(k) market clearance for AccuPlate® Patient-Specific Plates for mandibular reconstructive surgery.

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that the members of its management team will participate in a fireside chat hosted by LifeSci Capital on Wednesday, September 15, 2021 at 1:00 pm Eastern Time.

Creating the industry’s first powerful workflow innovation in more than 30 years for plasmid prep and polymerase chain reaction (PCR) cleanup, Beckman Coulter Life Sciences launches the EMnetik System to semi-automate workflows while drastically reducing the amount of time required to achieve a PCR cleanup.

Inspira Technologies OXY B.H.N. Ltd (“Inspira Technologies” or the “Company”) (NASDAQ: IINN) (NASDAQ: IINNW), announced today that it has submitted a patent application to the Israeli Patent Office for a supportive device to be utilized with its ART device.

The Novo Nordisk Foundation and the Broad Institute of MIT and Harvard announced today the launch of the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, an initiative that will accelerate efforts to mine genetic data for insights into disease mechanisms—and eventually rationally designed treatments.

Remedium Bio, Inc. is proud to announce it has entered into a Sponsored Research Agreement with Tufts University’s foremost Rheumatology laboratory to complete pre-clinical efficacy studies on Remedium’s lead gene therapy candidate

Immunexpress , Inc. today announced a presentation demonstrating comparative data of SeptiCyte® RAPID, lactate, and procalcitonin in differentiating sepsis from infection negative systemic inflammation at IDWeek 2021, taking place virtually on Sept. 29 – Oct. 3, 2021.

Cognito Therapeutics announced today its CEO Brent Vaughan will speak at CODE Conference , in Beverly Hills, CA, September 27-29, 2021 to discuss Cognito’s ground-breaking technology that has shown the promise of slowing or stopping the progression of Alzheimer’s and its potential to fundamentally expand human cognitive performance.

PhaseBio Pharmaceuticals, Inc. today announced the appointment of William D. Humphries to its board of directors.